MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results
CECO Environmental Reports Second Quarter 2026 Results
Bitdeer Reports Unaudited Financial Results for the Second Quarter of 2026
Auddia Announces SEC Effectiveness of S-4 Registration Statement Clearing Major Merger Milestone
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
McChip Provides Corporate Update
BrewDog Claims Londons Summer Park Season with ‘Park IPA’
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
Perion Reports Second Quarter 2026 Results